Bleeding Volume after Surgery for Trochanteric Fractures of the Femur in Patients Treated with Antiplatelet Agents: Comparison according to Surgical Timing.
10.12671/jkfs.2012.25.2.105
- Author:
Se Ang JANG
1
;
Young Ho CHO
;
Young Soo BYUN
;
Tae Gyun KIM
;
Hun Sik CHO
;
Sung CHOI
Author Information
1. Department of Orthopedic Surgery, Daegu Fatima Hospital, Daegu, Korea. femur1973@hanmail.net
- Publication Type:Original Article
- Keywords:
Femur;
Trochanteric fractures;
Antiplatelet agents;
Bleeding volume
- MeSH:
Female;
Femur;
Hemoglobins;
Hemorrhage;
Hip Fractures;
Humans;
Male;
Platelet Aggregation Inhibitors
- From:Journal of the Korean Fracture Society
2012;25(2):105-109
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We evaluated the bleeding volume after surgery for trochanteric fractures of the femur in patients treated with antiplatelet agents according to surgical timing. MATERIALS AND METHODS: We selected 20 patients who had trochanteric fractures of the femur treated with antiplatelet agents from January 2009 to June 2010. Group I included 9 patients who discontinued antiplatelet medication and had delayed operations at an average of 6.5 days and Group II included 11 patients who underwent early operations within 24 hours. Group I included 2 males and 7 females; their average age was 77.8 years (range 59~86). Group II included 4 males and 7 females, with an average age of 73.5 years (range 61~84). We compared the two groups' volume of intraoperative bleeding, the preoperative and postoperative hemoglobin levels and the volume of postoperative transfusion. The Mann-Whitney U test was used for statistical analysis. RESULTS: The volume of intraoperative bleeding was 88 ml in group I and 106 ml in group II (p>0.01). The difference in the hemoglobin was a decrease of 2.4 mg% in group I and a decrease of 2.2 mg% in group II (p>0.01). The volume of postoperative transfusion was 0.6 pints in group I and 1 pint in group II (p>0.01). CONCLUSION: We found a similar bleeding volume regardless of operative timing after surgery for trochanteric fractures of the femur in patients treated with antiplatelet agents.
